Abstract
The purpose of this study was to evaluate therapeutic response to neoadjuvant chemotherapy (NAC) and predict breast cancer recurrence using Positron Emission Tomography Response Criteria in Solid Tumors (PERCIST). Fifty-nine breast cancer patients underwent fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) before and after NAC prior to planned surgical resection. Pathological complete response (pCR) of the primary tumor was evaluated using PERCIST, while effects of clinicopathological factors on progression-free survival (PFS) were examined using log-rank and Cox methods. Fifty-six patients and 54 primary tumors were evaluated. Complete metabolic response (CMR), partial metabolic response, stable metabolic disease, and progressive metabolic disease were seen in 45, 7, 3, and 1 patients, respectively, and 43, 7, 3, and 1 primary tumors, respectively. Eighteen (33.3%) of the 54 primary tumors showed pCR. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of PERCIST to predict pCR were 100% (18/18), 30.6% (11/36), 41.9% (18/43), 100% (11/11), and 53.7% (29/54), respectively. An optimal percent decrease in peak standardized uptake value for a prima...Continue Reading
References
Aug 15, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B FisherH D Bear
Sep 5, 2002·Cancer·Edwin R FisherNorman Wolmark
Sep 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ana M Gonzalez-AnguloGabriel N Hortobagyi
Jan 29, 2008·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Masafumi KurosumiUNKNOWN Committee for Production of Histopathological Criteria for Assessment of Therapeutic Response of Japanese Breast Cancer Soci
Feb 9, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Priya RastogiNorman Wolmark
Feb 9, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen ChiaDavid A Mankoff
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Jun 24, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Richard L WahlMartin A Lodge
Mar 23, 2012·Radiology·Ukihide TateishiHomer A Macapinlac
May 30, 2013·Clinical Breast Cancer·Fabian Pius MghangaYongxue Zhang
Aug 10, 2013·European Journal of Nuclear Medicine and Molecular Imaging·Bas B KoolenRenato A Valdés Olmos
Oct 3, 2013·European Journal of Nuclear Medicine and Molecular Imaging·Judith E KalinyakMarie Tartar
Mar 17, 2016·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Tímea TőkésMagdolna Dank
Jul 13, 2016·The Oncologist·Sara SheikhbahaeiRathan M Subramaniam
Oct 16, 2016·Clinical and Translational Imaging : Reviews in Nuclear Medicine and Molecular Imaging·A CollarinoL M Pereira Arias-Bouda
Jan 11, 2017·Clinical Nuclear Medicine·Mutsumi NoritakeTakashi Ishikawa
Apr 22, 2017·Acta Radiologica·Eun Kyoung ChoiBong Joo Kang
Jul 22, 2017·Clinical Breast Cancer·Angela CollarinoLenka M Pereira Arias-Bouda
Jan 11, 2018·Seminars in Ultrasound, CT, and MR·Ashley I HuppeRachel F Brem
Mar 25, 2018·European Journal of Radiology·Soichi OdawaraKoichiro Yamakado
Citations
Feb 8, 2020·Nuclear Medicine Communications·Weiling LianZhongyi Yang
Mar 19, 2020·Nuclear Medicine Communications·Kazuhiro KitajimaRyogo Minamimoto
Dec 13, 2019·Oncotarget·Kazuhiro KitajimaKoichiro Yamakado
Jun 10, 2020·Nuclear Medicine Communications·Kazuhiro KitajimaKoichiro Yamakado
Apr 14, 2020·Cancer Medicine·Takahiro YokoseYuko Kitagawa
Jun 3, 2018·Annals of Nuclear Medicine·Takayuki KatsuuraKoichiro Yamakado
Jan 14, 2021·Scientific Reports·Miku SatoHironobu Sasano
Nov 2, 2020·Breast Cancer Research : BCR·Sangwon Han, Joon Young Choi
Apr 4, 2021·Cancers·Kazuhiro KitajimaKoichiro Yamakado
May 3, 2021·European Journal of Nuclear Medicine and Molecular Imaging·Hayato KaidaKazunari Ishii
Jun 18, 2021·Oncotarget·Kazuhiro KitajimaKoichiro Yamakado
Jul 25, 2021·Cancers·Valeria RomeoMarco Salvatore